SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001178913-25-000080
Filing Date
2025-01-10
Accepted
2025-01-10 16:06:21
Documents
16
Period of Report
2025-01-10
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zk2532537.htm   iXBRL 8-K 32080
2 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 16222
7 image00004.jpg GRAPHIC 6686
  Complete submission text file 0001178913-25-000080.txt   242045

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA entx-20250110.xsd EX-101.SCH 4794
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE entx-20250110_def.xml EX-101.DEF 17920
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE entx-20250110_lab.xml EX-101.LAB 27306
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE entx-20250110_pre.xml EX-101.PRE 20105
19 EXTRACTED XBRL INSTANCE DOCUMENT zk2532537_htm.xml XML 6720
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Filer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38556 | Film No.: 25522906
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)